Status:
UNKNOWN
Laser Assisted Treatment of Chronic Sinusitis With and Without Light Activated Agents
Lead Sponsor:
New York Head & Neck Institute
Collaborating Sponsors:
Valam Corp.
Conditions:
Rhinosinusitis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Chronic rhinosinusitis (CRS) is common disorder which affects up to 13% of the US population. CRS affects numerous Quality of Life (QOL) factors including smell, sleep and communication. The common tr...
Detailed Description
A prospective randomized trial that will be performed over the period of 1 year or until 20 patients in each arm meeting inclusion criteria will be recruited. One arm will be treated with a NIR laser ...
Eligibility Criteria
Inclusion
- Patients over 18
- Patients with an established nasal culture of either
- Staph aureus,
- Strep species,
- Pseudo monasaureginosa,
- Proteus.mirabilis,
- H. influenza
- or other intranasal pathogens.
Exclusion
- Patients without CRS,
- Patients known to have Iodide allergy or ICG allergy
- Patients scheduled for a thyroid scan
- Pregnant or breastfeeding.
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2011
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00948519
Start Date
May 1 2009
End Date
December 1 2011
Last Update
July 22 2011
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
St.Luke's-Roosevelt, New York Head Neck Institute
New York, New York, United States, 10019
2
Head Neck Surgical Group
New York, New York, United States, 10022
3
New York Head Neck Institute
New York, New York, United States